default author photo

Takeshi Masuda

Hiroshima University - Hiroshima University Hospital

Hiroshima, 734-8551

Japan

SCHOLARLY PAPERS

3

DOWNLOADS

133

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial

Number of pages: 42 Posted: 05 Dec 2025
affiliation not provided to SSRN, Shizuoka Cancer Center - Division of Thoracic Oncology, University of Tokyo - Department of Biostatistics and Bioinformatics, Shizuoka Cancer Center, affiliation not provided to SSRN, Shizuoka Cancer Center, Nagoya University, National Cancer Center Hospital East, National Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Hiroshima University - Hiroshima University Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Kanagawa Cancer Center, affiliation not provided to SSRN, Kansai Medical University, Kurume University - Department of Internal Medicine, Kyushu University, National Center for Global Health and Medicine, Niigata Cancer Center Hospital, Osaka City General Hospital, Kyoto University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, Kyushu University - Kyushu University Hospital and Shizuoka Cancer Center
Downloads 61 (1,031,043)

Abstract:

Loading...

locally advanced, Non-small cell lung cancer (NSCLC), older patients, chemoradiotherapy, daily low-dose carboplatin, carboplatin plus nab-paclitaxel

2.

A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients with Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring Met Exon 14 Alterations Who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)

Number of pages: 11 Posted: 29 Aug 2024
Kindai University, Nara Medical University, Kyushu University - Kyushu University Hospital, Sendai Kousei Hospital - Department of Pulmonary Medicine, Juntendo University, affiliation not provided to SSRN, Niigata Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Kindai University, Hiroshima University - Hiroshima University Hospital, Ehime University and Yamaguchi University
Downloads 42 (1,183,237)

Abstract:

Loading...

Lung cancer, MET, acquired resistance, cabozantinib, clinical trial

3.

Multicenter real-world data on first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer and performance status 2: WJOG18424L

Number of pages: 45 Posted: 01 Oct 2025
affiliation not provided to SSRN, Juntendo University, Shizuoka Cancer Center, Juntendo University, Wakayama Medical University, Kindai University, Sendai Kousei Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, Kanagawa Cancer Center, affiliation not provided to SSRN, Kindai University, Niigata Cancer Center Hospital, Osaka International Cancer Institute, Kobe University, Kyushu University - Kyushu University Hospital, Kobe City Medical Center General Hospital, Kanagawa Cardiovascular and Respiratory Center, Kumamoto University - Kumamoto University Hospital, Hiroshima University - Hiroshima University Hospital, Nagasaki University, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology, Kyushu University - Kyushu University Hospital and Juntendo University - Department of Respiratory Medicine
Downloads 30 (1,332,057)

Abstract:

Loading...

Non-small cell lung cancer, Performance status 2, Immune checkpoint inhibitors, Real-world evidence, First-line therapy